VSIG2 Antibody (541522) [Janelia Fluor® 635]
Novus Biologicals, part of Bio-Techne | Catalog # FAB51771JF635
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 635
Antibody Source
Monoclonal Mouse IgG1 Clone # 541522
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human VSIG2
Val24-Ala243
Accession # Q961Q7-1
Val24-Ala243
Accession # Q961Q7-1
Specificity
Detects human VSIG2 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for VSIG2 Antibody (541522) [Janelia Fluor® 635]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: VSIG2
Long Name
V-Set and Immunoglobulin Domain Containing 2
Alternate Names
CTH, CTXL
Additional VSIG2 Products
Product Documents for VSIG2 Antibody (541522) [Janelia Fluor® 635]
Product Specific Notices for VSIG2 Antibody (541522) [Janelia Fluor® 635]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...